In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.

Saved in:
Bibliographic Details
Title: In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
Authors: Reid J; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Zamuner S; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Edwards K; Statistics, GlaxoSmithKline, Stevenage, UK., Rumley SA; Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, UK., Nevin K; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Feeney M; Biopharm Research, GlaxoSmithKline, Stevenage, UK., Zecchin C; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Fernando D; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK., Wisniacki N; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 Oct; Vol. 84 (10), pp. 2280-2291. Date of Electronic Publication: 2018 Jul 12.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29900565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Reid+J%22">Reid J</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Zamuner+S%22">Zamuner S</searchLink>; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Edwards+K%22">Edwards K</searchLink>; Statistics, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Rumley+SA%22">Rumley SA</searchLink>; Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Nevin+K%22">Nevin K</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Feeney+M%22">Feeney M</searchLink>; Biopharm Research, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Zecchin+C%22">Zecchin C</searchLink>; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK.<br /><searchLink fieldCode="AU" term="%22Fernando+D%22">Fernando D</searchLink>; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Wisniacki+N%22">Wisniacki N</searchLink>; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503323%22">British journal of clinical pharmacology</searchLink> [Br J Clin Pharmacol] 2018 Oct; Vol. 84 (10), pp. 2280-2291. <i>Date of Electronic Publication: </i>2018 Jul 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7503323 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203065251%22">03065251 </searchLink><i>NLM ISO Abbreviation: </i>Br J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29900565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bcp.13669
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2280
    Titles:
      – TitleFull: In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Reid J
      – PersonEntity:
          Name:
            NameFull: Zamuner S
      – PersonEntity:
          Name:
            NameFull: Edwards K
      – PersonEntity:
          Name:
            NameFull: Rumley SA
      – PersonEntity:
          Name:
            NameFull: Nevin K
      – PersonEntity:
          Name:
            NameFull: Feeney M
      – PersonEntity:
          Name:
            NameFull: Zecchin C
      – PersonEntity:
          Name:
            NameFull: Fernando D
      – PersonEntity:
          Name:
            NameFull: Wisniacki N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2018 Oct
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2125
          Numbering:
            – Type: volume
              Value: 84
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: British journal of clinical pharmacology
              Type: main
ResultId 1